Connect Biopharma is trading 5.6% down at $1.02 on September 29, 2026; the reason for the decline remains unclear. - No company-specific announcement or fresh catalyst explaining the decline appeared in available search results; the latest listed company release was September 15. - Broader indexes are only modestly lower, which does not establish a clear market-wide cause for the sharper move. - No trading-volume information was provided.